House Oversight & Reform Committee Sets Hearing on Unsustainable Drug Prices Part 2
Sep 30, 2020 - Targeted News Service
The House Oversight and Reform Committee issued the following information for a hearing entitled: "Unsustainable Drug Prices: Testimony from the CEOs Part II" at 10 a.m. on Oct. 1 at 2154 Rayburn House Office Building, Washington, DC 20515:
Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, announced that the Committee will hold two days of hearings with top executives of major drug companies to examine their pricing practices for some of the costliest drugs ...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.